Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BRUKER CORPORATION

(BRKR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Bruker Corporation : to Participate in the 2021 Wells Fargo Virtual Healthcare Conference

08/30/2021 | 04:11pm EDT

Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Wells Fargo Virtual Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer, and Falko Busse, President of the Bruker BioSpin Group, will participate in an analyst moderated question and answer session on behalf of the Company on Friday, September 10, 2021 at 9:20 AM Eastern Time.

A live audio webcast of the question and answer session will be available on the Investor Relations section of the Company's website at https://ir.bruker.com . A replay will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.


ę Business Wire 2021
All news about BRUKER CORPORATION
10/18BRUKER : Announces Date and Time of Third Quarter 2021 Earnings Release and Webcast
BU
10/01BRUKER : NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Pro..
BU
10/01Bruker Corporation Receives Orders for Two 1.1 Ghz NMR Avance Neo Systems from U.S. Aca..
CI
09/27BRUKER : Tony Keller Recognized for Extraordinary Achievements in NMR with the Otto-Stern ..
PU
09/07BRUKER : Joins PANACEA Network to Broaden Access to NMR for European Chemistry Community
PU
09/02BRUKER : Flexible Molecular Biology Software Solution Combines Cloud with Desktop Function..
PU
08/31BRUKER CORPORATION : Ex-dividend day for
FA
08/30BRUKER CORPORATION : to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
BU
08/20BRUKER CORP : Change in Directors or Principal Officers (form 8-K)
AQ
08/11INSIDER TRENDS : Bruker Insider Sells Shares for Tax Slowing 90-Day Buy Trend
MT
More news
Analyst Recommendations on BRUKER CORPORATION
More recommendations
Financials (USD)
Sales 2021 2 365 M - -
Net income 2021 254 M - -
Net Debt 2021 194 M - -
P/E ratio 2021 46,9x
Yield 2021 0,20%
Capitalization 11 976 M 11 976 M -
EV / Sales 2021 5,15x
EV / Sales 2022 4,80x
Nbr of Employees 7 400
Free-Float 58,3%
Chart BRUKER CORPORATION
Duration : Period :
Bruker Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRUKER CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 79,30 $
Average target price 84,90 $
Spread / Average Target 7,06%
EPS Revisions
Managers and Directors
Frank H. Laukien Chairman, President & Chief Executive Officer
Gerald N. Herman Chief Financial Officer & Executive Vice President
William Alderman Linton Lead Independent Director
Richard A. Packer Independent Director
Hermann Fritz Requardt Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BRUKER CORPORATION46.50%11 976
THERMO FISHER SCIENTIFIC30.48%239 332
DANAHER CORPORATION37.80%219 325
INTUITIVE SURGICAL, INC.27.87%124 568
SIEMENS HEALTHINEERS AG42.35%77 688
EDWARDS LIFESCIENCES CORPORATION28.58%72 923